As of 2025-06-26, the Intrinsic Value of Replimune Group Inc (REPL) is -16.04 USD. This REPL valuation is based on the model Peter Lynch Fair Value. With the current market price of 9.45 USD, the upside of Replimune Group Inc is -269.73%.
Based on its market price of 9.45 USD and our intrinsic valuation, Replimune Group Inc (REPL) is overvalued by 269.73%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.04 - -16.04 | -16.04 | -269.73% |
| P/E | (41.70) - (81.48) | (65.68) | -795.0% |
| DDM - Stable | (22.78) - (56.88) | (39.83) | -521.4% |
| DDM - Multi | (19.03) - (37.80) | (25.40) | -368.8% |
| Market Cap (mil) | 728.50 |
| Beta | 1.83 |
| Outstanding shares (mil) | 77.09 |
| Enterprise Value (mil) | 689.29 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.47% |
| Cost of Debt | 5.00% |
| WACC | 10.88% |